Cargando…
Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
Spontaneous neoplasm metastasis, a fatalist pathological feature of cancer, is a long-evolving, multi-steps process that can now only be treated or controlled by drugs or immuno-modulators. As we have previously hypothesized, each drug or immuno-modulator might act differently within various stages...
Autores principales: | Lu, Da-Yong, Wu, Fu-Geng, Zhen, Zu-Ming, Lu, Ting-Ren, Wu, Hong-Ying, Che, Jin-Yu, Xu, Bin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002831/ https://www.ncbi.nlm.nih.gov/pubmed/21179367 http://dx.doi.org/10.3797/scipharm.0910-16 |
Ejemplares similares
-
Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
por: Lu, Da-Yong, et al.
Publicado: (2004) -
Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds
por: Hille, B van, et al.
Publicado: (1999) -
Absorption, Distribution and Excretion of (14)C-Probimane in Mice Bearing Lewis Lung Carcinoma
por: Lu, Da-Yong, et al.
Publicado: (2010) -
Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity
por: Bavlovič Piskáčková, Hana, et al.
Publicado: (2021) -
A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193
por: Ling, Elise M., et al.
Publicado: (2022)